Introduction: The aim of this study was to investigate whether serum levels of interleukin-1β (IL-1β) has any possible correlation on infl ammatory parameters such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and fi brinogen concentration in patients with familial Mediterranean fever (FMF) patients during attack-free period.
Introduction
Familial Mediterranean fever (FMF) is a group of inherited infl ammatory disorders that are characterized by recurrent episodes of fever accompanied by arthritis, peritonitis, pleuritis, erysipelas like erythema and seen dominantly in Mediterranean populations (1) . Mutations in MEFV gene, which encodes pyrin, a protein that regulates the infl ammatory process in immune cells, were reported as cause of FMF disease in 1997 (2, 3) . The traditional clinical view of the disease includes repeated acute short-lived febrile and painful attacks with variable periods of remission. The patients with FMF have an increased acute phase response during these attacks and usually this increase returns to normal in attack-free periods. Recent studies have demonstrated that subclinical infl ammation may continue during attack-free periods in approximately 30% of FMF patients (4) (5) (6) . The acute phase response of infl ammation involves the increase in serum level of liver-derived proteins (7). These proteins have diverse functions in the infl ammatory process. Infl ammation accompanied by a marked acute phase response such as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), serum amyloid A (SAA) and fi brinogen also plays an important function in the initiation and progres-
Interleukin-1β in familial Mediterranean fever sion of FMF (5) . Also, some researchers use to SAA protein levels as an important marker of chronic infl ammation in between attacks of FMF (6). Colchicine therapy commonly keeps from the attacks and related infl ammation (8) .
The cytokines that are produced throughout and took part in infl ammatory procedure are the principal stimulators of the manufacture of acute phase proteins (9) . Some cytokines and their receptors have been studied in patients with remission and attack periods of FMF disease. The serum levels of interleukin-1β (IL-1β), tumor necrosis factor-alpha (TNF-α), soluble interleukin-2 receptor (sIL-2R), interleukin-6 (IL-6) and interleukin-8 (IL-8) have been shown to be higher in patients at the attack periods than remission periods and control groups (10) (11) (12) (13) . IL-1β levels are increased in the blood of patients with a multiplicity of infectious, immune, or traumatic situations and play a fundamental role in infl ammation (9) . ESR is a comparatively nonspecifi c test that is regularly ordered during the diagnosis and scanning of infl ammatory diseases. CRP increase is a part of the acute phase response at acute and chronic infl ammation. It is mainly produced in the liver and released in six hours with increased amounts when acute infl ammatory stimulus began (14) . Fibrinogen, a protein that is made in the liver excessively, is vital for the blood clotting process. A number of studies have been reported activated cytokine network during attacks of FMF. However, cytokine activity is not known clearly in FMF during attackfree period. Especially, there has been no adequate study investigating serum IL-1β levels in patients with FMF in between attacks. Therefore, present study was performed to determine IL-1β, ESR, CRP and fi brinogen concentration as indicators of infl ammation status and the relationship among these parameters in patients with FMF during attack-free period.
Materials and methods

Subjects
This study was conducted during in the period from 2009 to 2010 at the Physical Medicine and Rehabilitation Outpatients Clinics. This study was approved by the local Ethics Committee. All the participants were informed of the study protocol and their written informed consents, according to the Declaration of Helsinki, were obtained. In the present study groups comprised 35 FMF patients in attack-free period (male gender, N (ratio): 10 (0.29)), and 25 age and sex matched healthy controls (male gender, N (ratio): 9 (0.36)). The subjects aged 18-60 years were recruited in the study. Thirty fi ve patients who fulfi lled clinical diagnostic criteria for FMF (15) were consecutively included in the study. Attack-free periods were defi ned as being free of attacks for at least 3 weeks. All of the patients were receiving regular colchicine treatment during study (1-1.5 mg/day). Control subjects were healthy subjects without a history of infl ammatory or general disease. A detailed medical history was taken and clinical examinations were performed on all participants. The healthy subjects and patients were not habituated to smoking and/or alcohol consumption. Patients with liver and kidney diseases, diabetes, peripheral neuropathy, familial hypercholesterolemia, thyroid and parathyroid diseases, hematological, lymphoproliferative and other malignant diseases were excluded after this status was self-declared by the individuals. Aforementioned disease statuses were also controlled from their medical records.
Methods
All blood samples were obtained at attack-free periods and stored at -80 °C until analysis during one year. Fasting serum samples were collected during morning hours to avoid diurnal variations. 
Results
The demographic and clinical characteristics of 35 FMF patients and 25 volunteer control subjects are shown in Table 1 . There were no statistically significant diff erences between the two groups with respect to demographic data. Table 2 summarizes laboratory fi ndings such as IL-1β, ESR, CRP and fibrinogen levels in the study population and control groups. The serum levels of IL-1β in attack-free patients with FMF were signifi cantly higher than in the healthy controls (P = 0.018), but not other parameters of infl ammation, including ESR, CRP and fi brinogen (P = 0.181, P = 0.816, P = 0.686, respectively).
There was a positive correlation between serum IL-1β and CRP (r = 0.513, P = 0.002), in patients with FMF. However, there were no correlations between IL-1β and ESR and fi brinogen.
Discussion
FMF is an autosomal recessive disorder that characterized by the exacerbations and remissions (16) . Duration and frequency are not presumable. Its clinical course is characterized by recurrent selflimited attacks of fever and polyserositis at irregular intervals, accompanied with an increase in acute phase reactants (1,2). Acute phase proteins, whose synthesis is altered during infl ammation, injury and infections, are probably aff ected by interleukins, released from the site of injury or infl ammation (17) . These acute phase proteins comprise ESR, CRP, fi brinogen, SAA and alpha 1-acid glycoprotein. The major inducers of acute phase proteins are IL-1, IL-6, and TNF-α (18). Attacks of FMF are accompanied by an intense infl ammatory response (9) . In literature, elevated plasma concentration of acute phase reactants like ESR, CRP and fi brinogen and elevated serum cytokines levels such as IL-1β have been determined during the attack periods (13, 19) . However, there is still no adequate study investigating serum IL-1β values in FMF patients with attack-free period. Notarnicola et al. (20) have investigated TNF-α, IL-1β, IL-6 and IL-8 cytokine expression at the transcriptional level. They have reported that these parameters were more elevated in attack-free FMF patients than in controls. In our study, serum IL-1β levels are signifi cantly higher the attack-free period of FMF than the controls. In contrast to our and Notarnicola's studies, Gang et al. showed that levels of IL-1β were not elevated in FMF patients during attacks or attack-free periods (18) . The diff erence between results may be due to the determi- nation time of FMF phase, age group of patients and processes and method of IL-1β determination.
On the other hand, some biological variations of the components such as cytokines in biological fl uids of the human body have been reported (21) . The confl ict results on serum IL-1β levels may also due to inter-individual and intra-individual biological variation. However, these fi ndings still suggest a continuing pro-infl ammatory state and subclinical infl ammation in attack-free period of patients with FMF receiving regular colchicine drug (19) (20) (21) (22) .
In the present study, ESR, CRP and fi brinogen levels were not signifi cantly diff erent in patients with FMF at attack-free period when compared to healthy control group. Similar fi ndings have been established by other recent studies. In a previous study CRP levels of attack free-FMF patient were higher than healthy control groups (5). In our study, CRP levels of FMF patient were not signifi cantly higher than healthy controls. However, only fi ve patients were over the normal range. In the literature, it was reported that approximately 30% of FMF patients have a chronic subclinical infl ammation with elevated acute phase reactants during attack free periods (6) . These contradictory results of diff erent studies may be due to diff erent infl ammation phase in patients with attack free period. Although our study had some limitations such as the small number of patients, our results suggest that the elevation of IL-1β levels may be important in monitoring subclinical infl ammation of attack free period in FMF patients. Further studies are needed to defi ne the relationship between IL-1β values and infl ammation in a large group of patients.
